← All companies
DELFI Diagnostics, Inc. logo

DELFI Diagnostics, Inc.

8 open jobs

DELFI Diagnostics is developing next-generation, blood-based tests for early cancer detection using advanced machine-learning methods and whole-genome sequencing data. The company's DELFI platform employs fragmentomics technology to identify cancer cells through patterns in cell-free DNA fragments, with FirstLook Lung as their first laboratory-developed screening test.